Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.65 |
| ▸ | RECQL | P46063 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.64 |
| ▸ | APP | P05067 | 1/20 | 0.64 |
| ▸ | XDH | P47989 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27796495 | 1.00 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL15530038 | 0.89 | SOST (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL29929436 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL29397807 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL29929680 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL6819045 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Dihydromorin SCHEMBL10174295 | 0.89 | MAPT (0.65) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Pinobaksin SCHEMBL1045054 | 0.84 | MAPT (0.75) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| Pinobaksin SCHEMBL14461145 | 0.84 | MAPT (0.75) | MAPTCYP3A4ALOX15RECQLMEN1 | |
| SCHEMBL28841492 | 0.84 | MAPT (0.67) | MAPTCYP3A4ALOX15RECQLMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024220998-A9 | ORALLY BIO AVAILABLE PHARMACEUTICAL CRYSTALS AND SALTS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-03-06 | — | — | WO | disclosed |
| WO-2024220998-A1 | ORALLY BIO A VAILABLE PHARMACEUTICAL CRYSTALS AND SALTS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-10-24 | — | — | WO | disclosed |
| CN-104274455-B | The preparation method of quercetin derivative containing benzyl diethylenediamine and its to the protective effects on gastric mucosa | 山东理工大学 | 2018-04-27 | — | — | CN | disclosed |
| US-20150237900-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE | CHROMOCELL CORP (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150237900-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE | CHROMOCELL CORP (US) | 2015-08-27 | — | — | US | disclosed |
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2010-01-14 | — | — | US | disclosed |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | EXCRX (SINGAPORE) PTE. LTD. (F.K.A. COMBINATORX (SINGAPORE) PTE LTD.) (SG) | 2008-07-03 | — | — | US | disclosed |
| WO-2008033466-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PRE. LTD. (SG) | 2008-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | HTR1A, HTR3B, HTR3A | MAPT 1527/4885CYP3A4 403/4885ALOX15 4165/4885 |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | HAVCR2, EIF2AK2, RNASE1 | MAPT 3341/4885CYP3A4 1342/4885ALOX15 2694/4885 |
| US-20150237900-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING OR ELIMINATING BITTER TASTE | TAS2R5, TAS2R20, TAS2R10 | MAPT 4340/4885CYP3A4 3973/4885ALOX15 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.